Company Overview and News

 
San Miguel halves food unit share sale, seeks $920 million

2h bworldonline
MANILA/SINGAPORE — Philippine conglomerate San Miguel Corp. said it is looking to raise about $920 million through a sale of shares in its food unit, slashing the size of the offering by almost half due to weakness in the stock market.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
Boracay beaches now wider, cleaner

20h newsinfo.inquirer.net
BORACAY ISLAND — For the past several months, Robert Samindao has been driving Boracay residents around the 1,032-hectare island on his motorcycle for a living.
SMGBF SMC2B SMC2A SMC SMC2D MWC SMC2C SMCP1 SMC2F SMC2E SMGBY

 
Boracay safe for swimming, says Cimatu; ‘dry run’ starts

2018-10-15 newsinfo.inquirer.net
ENTRY POINT Tourists going to Boracay arrive at Boat Station 3, the only entry point to the resort island, as the government begins a 10-day “dry run” on Monday following a six-month closure due to environmental concerns and ongoing road and sewage projects. —ETO PAGADUAN
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
Parents deported from U.S. may lose kids to adoption

2018-10-11 usa.inquirer.net
Araceli Ramos walks with her five-year-old daughter, Alexa, in a park in San Miguel, El Salvador, on Aug. 18, 2018. An Associated Press investigation drawing on hundreds of court documents, immigration records and interviews in the U.S. and Central America identified holes in the system that allow state court judges to grant custody of migrant children to American families, without notifying their parents.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
Beermen out to break 3-game losing streak

2018-10-11 bworldonline
THE slumping San Miguel Beermen are out to break from a three-game losing streak in the Philippine Basketball Association Governors’ Cup when they face off with in-form Phoenix Fuel Masters in league action today at the Mall of Asia Arena.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
2 dead as truck loses brakes, sideswipes 7 other vehicles

2018-10-09 newsinfo.inquirer.net
PAGADIAN CITY— A six-wheeler truck loaded with fish lost its brakes and went out of control while traversing the national highway in Barangay Paglaum, Dumalinao town in Zamboanga del Sur at 9 a.m. on Tuesday. It sideswiped seven vehicles, killing two drivers and injuring seven persons.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
Duterte OKs ‘unimpeded’ rice importation, says Roque

2018-10-09 newsinfo.inquirer.net
President Rodrigo Duterte has authorized the “unimpeded” rice importation in the country to lower the prices of the staple food.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
Star toll plazas now RFID-ready

2018-10-08 bworldonline
THE TOLL plazas of the Southern Tagalog Arterial Road (Star) Tollway now have RFID (radio-frequency identification) technology, allowing seamless travel through the 42-kilometer highway connecting Santo Tomas town and Batangas City. In a statement yesterday, San Miguel Corp. subsidiary Star Tollway Corp., operator of the toll road, said “Autosweep RFID payment lanes, alongside regular cash lanes, are now operational at the toll plazas.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
Foreign funds still leaving PH stock market

2018-10-05 business.inquirer.net
The local stock barometer was flat on Friday as foreign outflows continued even as the latest September inflation report was not as bad as initially feared.
SVTMF PSKXF SMCP1 GTMEY AYAAY SM GLOPP SMGBY SMGBF GLO SMC2B SMIVY SMC2A SMC SMC2D SMC2C SMC2F SMC2E PHSXY GTMEF PSE GLOPA ALI AYAAF

 
SMFB’s P142-B equity offering OKd

2018-10-04 business.inquirer.net
The Securities and Exchange Commission (SEC) has approved an equity offering of as much as P141.8 billion planned by consumer powerhouse San Miguel Food and Beverage Inc. (SMFB), potentially the largest equity deal in the history of the local stock market.
PSKXF SMCP1 SMGBY SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMC2F SMC2E PHSXY PSE GSMI

 
SEC approves San Miguel food subsidiary’s P142.81-billion follow-on offering

2018-10-04 bworldonline
THE SECURITIES and Exchange Commission (SEC) has given the go signal for San Miguel Food and Beverage, Inc. (SMFB) to conduct its P142.81-billion follow-on offering, slated to be the largest share sale in the history of the Philippine equities market.
PFP DB SMCP1 PF SMPFY PFP2 SMGBY SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMC2F SMC2E GSMI LTG SMPFF

 
SEC approves SMFB’s P142B ‘re-IPO’

2018-10-04 business.inquirer.net
The Securities and Exchange Commission (SEC) approved on Thursday an equity offering of as much as P141.8 billion planned by consumer powerhouse San Miguel Food and Beverage Inc. (SMFB), potentially the largest equity deal in the history of the local stock market.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E GSMI SMGBY

 
SMC champions rice husks to address clean energy, food security dilemmas

2018-10-03 business.inquirer.net
The San Miguel group is looking at energy from rice husks as part of a plan to convert two of its coal-fired power plants into biomass facilities as a means to harness cleaner electricity while boosting the agriculture sector.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
San Miguel plans power plants’ transition to biomass technology

2018-10-03 bworldonline
SAN MIGUEL Corp. (SMC) said on Wednesday that it was planning to replace coal with rice husks to fuel its circulating fluidized bed (CFB) power plants to boost the income of farmers while the conglomerate moves towards renewable and sustainable energy generation.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

 
Rain or Shine looks to arrest bad start in Governors’ Cup

2018-10-02 bworldonline
HAVING opened their Philippine Basketball Association Governors’ Cup campaign with two straight losses, the Rain or Shine Elasto Painters look to break through the win column when they take on the Alaska Aces today at the Smart Araneta Coliseum.
SMGBF SMC2B SMC2A SMC SMC2D SMC2C SMCP1 SMC2F SMC2E SMGBY

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...